Sagimet Biosciences Inc. Series A Common Stock (NASDAQ: SGMT) last traded at $8.80, down 1.46% on the session. The quote above updates while this page is open; the figures below are drawn from Sagimet Biosciences Inc. Series A Common Stock’s own filings and are restated only when a new one is published.
Sagimet Biosciences Inc. Series A Common Stock trades on NASDAQ under the ticker SGMT. Its market capitalisation is $467.41 million.
Valuation measures for Sagimet Biosciences Inc. Series A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $467.41M |
|---|---|
| Enterprise value | $308.79M |
| Price / book | 1.82 |
| Beta | 1.93 |
Trailing-twelve-month figures tagged in Sagimet Biosciences Inc. Series A Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$47.08M |
|---|
| Return on equity | -18.38% |
|---|
| Cash | $165.90M |
|---|
Range and volume for SGMT over the past 52 weeks.
| 52-week high | $11.45 |
|---|---|
| 52-week low | $4.50 |
| Volume | 1.08M |
| Average volume | 1.23M |
| Previous close | $8.93 |
Invest a chosen dollar amount in Sagimet Biosciences Inc. Series A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SGMT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.